A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus
Clinical trial NCT07751848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07751848
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-04
- Primary completion
- 2028-08-25
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.